Coronavirus
NPHCDA to address infrastructural gaps in COVID-19 vaccine supply
The Minister disclosed that the NPHCDA is currently assessing gaps related to challenges in the distribution of COVID-19 vaccine.
The Federal Government stated that the National Primary Health Care Development Agency (NPHCDA) with its partners, is working to fix healthcare value chain roadblocks that may affect the fair distribution of Covid-19 vaccines.
This was disclosed on Tuesday in Abuja by the Minister of State for Health, Sen. Olorunnimbe Mamora, at the daily Presidential Task Force briefing on Covid-19.
READ: Incomes and consumption of Nigerian households remain unstable due to COVID-19
The Minister disclosed that the agency is currently assessing gaps related to distribution challenges. He said,
- “In terms of vaccines, the lead agency, NPHCDA, working with partners, is currently assessing the infrastructural gaps in terms of logistics for cold chain maintenance, storage, supply and distribution. We are also working with the Aviation Ministry to ensure strict enforcement of COVID-19 protocols at the local and international wings of airports across the country, taking cognisance of the high transmissibility of the new strain of the virus already confirmed in many countries.
- “Particular attention in this regard is therefore being focused on passengers arriving from the UK and South Africa. We appeal to all states to increase testing to enable us to know exactly where we are. This will enable us to put in place measures to check transmission and provide treatment for patients.”
READ: Africa left with few options to procure Covid-19 vaccines – South Africa’s President
The Minister added that the FG is also working to ensure the availability of oxygen tanks in hospitals.
- “The Federal Government has been making spirited efforts at ensuring availability of oxygen on a short term basis through collaboration with CACOVID, while pursuing the process for nationwide equitable and sustainable oxygen availability at federal tertiary hospitals as well as state-owned hospitals.
- “It is important to state that the ultimate plan in terms of medical oxygen supply is based on systematic oxygen assessment and gaps identification in the country, bordering on severe disequilibrium, uneven storage/demand ratio, distribution logistics challenges and equipment and plant dilapidation.
- “Our oxygen availability intervention plan is targeted at immediate, medium and long-term plans with special attention to COVID-19 high burden areas such as FCT, Lagos and Kaduna.”
READ: FG suspends passports of 100 Nigerians for refusing post-arrival Covid-19 test
What you should know
- Nairametrics reported last month that the Federal Ministry of Health (FMOH) disclosed that the Health Sector Next Level Agenda will boost primary healthcare in Nigeria and also catch up with healthcare-related gaps by as much as 60% through the implementation of the Sustainable Development Goals (SDGs).
- The Minister of Health, Dr Osagie Ehanire, also stated that Nigeria is ready for its Covid-19 vaccination strategy, revealing that the FG plans to acquire vaccines valued at N400 billion.
READ: Foreign investors jostling to exploit Nigeria’s $82 billion healthcare gap
Business News
COVID-19 Update in Nigeria
On the 20th of April 2021, 120 new confirmed cases were recorded in Nigeria
The spread of novel Corona Virus Disease (COVID-19) in Nigeria continues to record significant increases as the latest statistics provided by the Nigeria Centre for Disease Control reveal Nigeria now has 164,423 confirmed cases.
On the 20th of April 2021, 120 new confirmed cases were recorded in Nigeria.
To date, 164,423 cases have been confirmed, 154,406 cases have been discharged and 2,061 deaths have been recorded in 36 states and the Federal Capital Territory.
A total of 1.84 million tests have been carried out as of April 20th, 2021 compared to 1.81 million tests a day earlier.
COVID-19 Case Updates- 20th April 2021,
- Total Number of Cases – 164,423
- Total Number Discharged – 154,406
- Total Deaths – 2,061
- Total Tests Carried out – 1,838,174
According to the NCDC, the 120 new cases are reported from 8 states- Enugu (53), Lagos (22), Rivers (18), Ogun (8), FCT (7), Abia(6), Kano (5) and Bauchi (1).
Meanwhile, the latest numbers bring Lagos state total confirmed cases to 58,119, followed by Abuja (19,756), Plateau (9,035), Kaduna (9,014), Rivers (7,060), Oyo (6,839), Edo (4,897), Ogun (4,639), Kano (3,942), Ondo (3,226), Kwara (3,120), Delta (2,617), Osun (2,572), Nasarawa (2,380), Enugu (2,281), Katsina (2,097), Gombe (2,034), Ebonyi (2,020), Anambra (1,909), Akwa Ibom (1,843), and Abia (1,683).
Imo State has recorded 1,655 cases, Bauchi (1,540), Borno (1,337), Benue (1,188), Adamawa (1,063), Niger (930), Taraba (910), Bayelsa (885), Ekiti (869), Sokoto (775), Jigawa (527), Kebbi (450), Cross River (394), Yobe (365), Zamfara (240), while Kogi state has recorded 5 cases only.
READ ALSO: COVID-19: Western diplomats warn of disease explosion, poor handling by government
Lock Down and Curfew
In a move to combat the spread of the pandemic disease, President Muhammadu Buhari directed the cessation of all movements in Lagos and the FCT for an initial period of 14 days, which took effect from 11 pm on Monday, 30th March 2020.
The movement restriction, which was extended by another two weeks period, has been partially put on hold with some businesses commencing operations from May 4. On April 27th, 2020, Nigeria’s President, Muhammadu Buhari declared an overnight curfew from 8 pm to 6 am across the country, as part of new measures to contain the spread of the COVID-19. This comes along with the phased and gradual easing of lockdown measures in FCT, Lagos, and Ogun States, which took effect from Saturday, 2nd May 2020, at 9 am.
On Monday, 29th June 2020 the federal government extended the second phase of the eased lockdown by 4 weeks and approved interstate movement outside curfew hours with effect from July 1, 2020. Also, on Monday 27th July 2020, the federal government extended the second phase of eased lockdown by an additional one week.
On Thursday, 6th August 2020 the federal government through the secretary to the Government of the Federation (SGF) and Chairman of the Presidential Task Force (PTF) on COVID-19 announced the extension of the second phase of eased lockdown by another four (4) weeks.
Governor Babajide Sanwo-Olu of Lagos State announced the closed down of the Eti-Osa Isolation Centre, with effect from Friday, 31st July 2020. He also mentioned that the Agidingbi Isolation Centre would also be closed and the patients relocated to a large capacity centre.
Due to the increased number of covid-19 cases in Nigeria, the Nigerian government ordered the reopening of Isolation and treatment centres in the country on Thursday, 10th December 2020.
On 26th January 2021, the Federal Government announced the extension of the guidelines of phase 3 of the eased lockdown by one month following the rising cases of the coronavirus disease in the country and the expiration of phase 3 of the eased lockdown.
On 28th February 2021, the federal government confirmed that the first tranche of Covid-19 vaccines will arrive in Nigeria on Tuesday, March 2nd, 2021.
On Tuesday, 2nd March 2021, the National Primary health Care Development Agency announced the arrival of the expected COVX Astrazeneca/Oxford covid-19 vaccines.
On Saturday, 6th March 2021, President Muhammadu Buhari and his vice, Yemi Osinbajo received vaccination against the covid-19 as the State House in Abuja.
READ ALSO: Bill Gates says Trump’s WHO funding suspension is dangerous
Coronavirus
FG explains how the Covid-19 vaccines work and their composition
The NPHCDA Director said that Covid-19 vaccine candidates are of various categories based on their mechanism of action.
The Federal Government through the National Primary Health Care Development Agency (NPHCDA) has explained the composition of the Covid-19 vaccines and how they work.
This is as some of them have been approved for emergency use by the World Health Organization (WHO) and some countries, while others are still at different phases of clinical trials for possible approval.
According to a report from the News Agency of Nigeria (NAN), this insight was given by the Executive Director/Chief Executive of NPHCDA, Dr Faisal Shuaib, who said there were several COVID-19 vaccine candidates.
READ: African Union signs deal for 400 million Johnson and Johnson single shot vaccine
He said that Covid-19 vaccine candidates are of various categories based on their mechanism of action such as the inactivated or weakened virus vaccines.
He explained that the idea behind the formulation of an inactivated or weakened virus vaccine is to elicit an immune response without causing the disease itself. Shuaib also said there were protein-based vaccines, which used harmless fragments of proteins or protein shells that mimic the Covid-19 virus to safely generate an immune response.
He added that the viral vector vaccines used a virus that had been genetically engineered to produce coronavirus proteins to safely generate an immune response and not give rise to the disease.
Going further, Shuaib pointed out that the Ribonucleic Acid (RNA) and Deoxyribonucleic Acid (DNA) vaccines employed a cutting-edge approach that used genetically engineered RNA or DNA to generate a protein that safely prompted an immune response.
READ: China publicly presents its COVID-19 vaccines, 2 doses to cost below $146
What you should know
- It can be recalled that on March 2, 2021, Nigeria received the first set of about 4 million doses of the AstraZeneca Covid-19 vaccine, manufactured by the Serum Institute in India and shipped via the COVAX Facility, a partnership between CEPI, Gavi, UNICEF and WHO.
- A few days ago, the Executive Director of NPHCDA disclosed that a total of 8,491 Nigerians have reacted adversely to the AstraZeneca inoculation since the exercise began on March 15.
- He said that Nigeria recorded 52 cases of moderate to severe incidents of Adverse Effects Following Immunisation (AEFI), presented as fever, vomiting, diarrhoea headaches, dizziness and allergic reactions.
- About 1.09 million Nigerians have so far been administered the first dose of the AstraZeneca Covid-19 vaccine.
